All systems operational
Q3 2025

IL- 33 and sST- 2 association with carotid intima-media thickness in patients with Ankylosing Spondylitis

Omnia Abubakr · Wessam Guergues · Lamyaa Salem · Marwa Kamel
10.1186/s43166-025-00324-6 380 Views 0 Citations
0
Citations
380
Views
Abstract

Abstract

Background
Cardiovascular disease is the main cause of death in patients with ankylosing spondylitis (AS). Previous studies showed high serum levels of IL- 33 in AS patients and suggested that it may play a role in disease development. However, the possible role of IL- 33/sST- 2 in atherosclerosis in AS has not been investigated.


Objectives
To assess serum levels of IL- 33 and sST- 2 and to assess their association with carotid intima-media thickness (CIMT) and disease activity in a group of Egyptian patients with AS.


Results
Serum levels of IL- 33 and sST- 2 were statistically higher in AS patients compared to controls (median, 451.75 vs 37.42, p = 0.000) and (median, 5.71 vs 0.74, p = 0.000) respectively. IL- 33 and sST- 2 levels positively correlated with Bath Ankylosing Spondylitis Disease Activity Index (r = 0.445, p = 0.004) and (r = 0.421, p = 0.007) respectively, and Ankylosing Spondylitis Disease Activity Score with CRP (r = 0.684, p = 0.000) and (r = 0.452, p = 0.003) respectively. There was a positive correlation between serum IL- 33/sST- 2 and CIMT.


Conclusion
The high serum levels of IL- 33 and sST- 2 in AS patients and their positive correlation with CIMT and AS disease activity suggest that IL- 33/ST2 axis-induced inflammation may be a major factor in the development of cardiovascular disease in AS patients.

Cite this Article (APA)
Omnia, A., Wessam, G., Lamyaa, S., Marwa, K. (2025). IL- 33 and sST- 2 association with carotid intima-media thickness in patients with Ankylosing Spondylitis. Egyptian Rheumatology and Rehabilitation. https://doi.org/10.1186/s43166-025-00324-6
Related Papers
Sleep quality, anxiety, depression, and quality of life in rheumatoid arthritis patients and impact …
Maha S. I. Abdelrahman; Ahmad M. Shaddad; Waleed Gamal Elddin Khaleel; Esraa A. · 2024
14
cites
393
Serum malondialdehyde as a marker of oxidative stress in rheumatoid arthritis
Ghada A. Nabih; Nehal EEl Sheshtawy; Dalia M. E. El Mikkawy; Marwa A. Kamel · 2024
13
cites
399
Vitamin D management update: evidence-based guidelines for vitamin D optimization by the Egyptian Ac…
Yasser El Miedany; Mathias Toth; Maha Mohamed El Gaafary; Safaa A. Mahran; Walee · 2025
10
cites
396
TNF-α in the serum and synovial fluid of patients with rheumatoid arthritis: correlation with sonogr…
Aya El Hassany; Samar Tharwat; Mostafa Mansour; Asmaa Farouk Enein · 2024
8
cites
394
Screening to prevent osteoporotic fractures in Egypt: a position statement of the Egyptian Academy o…
Yasser El Miedany; Maha El Gaafary; Naglaa Gadallah; Safaa Mahran; Mohamed Hassa · 2024
7
cites
396
Access
View Full Text via DOI
Published in
ISSN 2090-3235
Quartile Q3
AMS Score 76
Field Medicine & Health Sciences
Publisher Springer (Biomed Central Ltd.)
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2025
Language English
Added 14 Aug 2026